Comorbidity guide
Meta-analytic data from Elrod and Hood (2015) established that 50-80% of autistic children experience clinically significant sleep problems. The most common issue is prolonged sleep onset latency (taking more than 30 minutes to fall asleep), reported in up to 67% of autistic children. Night wakings affect approximately 45%, and early morning waking affects 25%.
Multiple mechanisms contribute to sleep difficulties in autism. Altered melatonin production and metabolism have been documented, with autistic individuals showing lower evening melatonin levels and atypical circadian rhythms. Sensory hypersensitivities to light, sound, and tactile input interfere with sleep initiation. Anxiety and difficulty with transitions (including the transition from wakefulness to sleep) compound the problem.
Chronic sleep deprivation exacerbates autism-related challenges. Research shows that poor sleep is associated with increased repetitive behaviours, greater social difficulties, more frequent meltdowns, and reduced learning capacity. Addressing sleep should be a priority in any comprehensive intervention plan.
Behavioural sleep interventions are the recommended first-line treatment. These include: establishing a consistent visual bedtime routine, optimizing the sleep environment (cool, dark, quiet, weighted blanket if desired), removing screens 60 minutes before bed, using social stories about sleep, and graduated extinction approaches for children who resist independent sleep.
Melatonin supplementation has strong evidence for improving sleep onset in autistic children. A 2019 randomized controlled trial by Malow et al. demonstrated that pediatric-formulation melatonin reduced sleep onset latency by an average of 39 minutes. Starting doses of 1-3 mg given 30-60 minutes before target bedtime are typical. In Canada, melatonin is available over the counter but should be used under medical guidance for children.
Ontario sleep resources include pediatric sleep clinics at SickKids (Toronto), McMaster Children's Hospital (Hamilton), CHEO (Ottawa), and regional Children's Treatment Centres. Referrals from pediatricians are typically required, and wait times range from 3 to 12 months.
Elrod, M.G. & Hood, B.S.
Sleep Differences Among Children With Autism Spectrum Disorders and Typically Developing Peers: A Meta-Analysis. Developmental Medicine & Child Neurology, 2015; 57(11):1017-1023
Malow, B.A. et al.
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children with ASD. J American Academy of Child & Adolescent Psychiatry, 2019; 60(2):252-261
Written by Spencer Carroll
Founder & Autism Advocate
Evidence on this page
Key claims are paired with their source, evidence tier, and verification date so readers can inspect the public record directly.
1 in 50
According to the 2019 Canadian Health Survey on Children and Youth, about children and youth aged 1 to 17 in Canada had an autism diagnosis
89,799
children are registered in the Ontario Autism Program
WHO recommends accessible, community-based early interventions for children with autism — timely evidence-based psychosocial interventions improve communication and social engagement
23%
Only 20,633 children have active funding agreements — less than one in four